Clinical Trial Update: Gadobutrol/Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD) [Phase 3]

View source ↗

Summary

Phase 3 trial results for gadobutrol-enhanced cardiac MRI (Gadavist) to detect coronary artery disease have been posted after the study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Gadavist (gadobutrol)

Snippet

Sponsor: Bayer | Conditions: Coronary Artery Disease | Phase 3 | Status: COMPLETED | Results posted: 2018-05-16